Similar favorable outcome of pegfilgrastim overdose in patients with different age and underlying disease.
作者信息
Dufour Carlo, Cappelli Barbara, Calvillo Michaela, Fioredda Francesca, Tonelli Rossella, Crocchiolo Roberto
出版信息
Haematologica. 2010 Apr;95(4):684-5. doi: 10.3324/haematol.2009.018333. Epub 2010 Jan 6.
Abstract
摘要
相似文献
1
Similar favorable outcome of pegfilgrastim overdose in patients with different age and underlying disease.
Haematologica. 2010 Apr;95(4):684-5. doi: 10.3324/haematol.2009.018333. Epub 2010 Jan 6.
2
Overdose of pegfilgrastim: case report.
Int J Clin Pharm. 2012 Oct;34(5):690-2. doi: 10.1007/s11096-012-9653-z. Epub 2012 Jul 21.
3
Pegfilgrastim and daily granulocyte colony-stimulating factor: patterns of use and neutropenia-related outcomes in cancer patients in Spain--results of the LEARN Study.
Eur J Cancer Care (Engl). 2009 May;18(3):280-6. doi: 10.1111/j.1365-2354.2008.00959.x. Epub 2008 Dec 8.
4
Respiratory distress and sudden death of a patient with GSDIb chronic neutropenia: possible role of pegfilgrastim.
Haematologica. 2009 Aug;94(8):1175-7. doi: 10.3324/haematol.2008.005330.
5
Pegfilgrastim.
Drugs. 2002;62(8):1207-13; discussion 1214-5. doi: 10.2165/00003495-200262080-00012.
6
Once-per-cycle pegfilgrastim versus daily filgrastim in pediatric patients with Ewing sarcoma.
J Pediatr Hematol Oncol. 2005 Aug;27(8):449-51. doi: 10.1097/01.mph.0000175711.73039.63.
7
Safety and efficacy of pegfilgrastim compared to granulocyte colony stimulating factor (G-CSF) supporting a dose-intensive, rapidly cycling anti-metabolite containing chemotherapy regimen (Hyper-CVAD) for lymphoid malignancy.
Leuk Lymphoma. 2006 Sep;47(9):1813-7. doi: 10.1080/10428190600632832.
8
Safety and efficacy of pegfilgrastim in patients receiving myelosuppressive chemotherapy.
Pharmacotherapy. 2003 Aug;23(8 Pt 2):15S-19S. doi: 10.1592/phco.23.9.15s.32889.
9
Pegfilgrastim.
Expert Opin Biol Ther. 2002 Dec;2(8):985-92. doi: 10.1517/14712598.2.8.985.
10
A single dose of pegfilgrastim compared with daily filgrastim for supporting neutrophil recovery in patients treated for low-to-intermediate risk acute myeloid leukemia: results from a randomized, double-blind, phase 2 trial.
BMC Cancer. 2008 Jul 10;8:195. doi: 10.1186/1471-2407-8-195.
引用本文的文献
1
Assessing the Optimal Regimen: A Systematic Review and Network Meta-Analysis of the Efficacy and Safety of Long-Acting Granulocyte Colony-Stimulating Factors in Patients with Breast Cancer.
Cancers (Basel). 2023 Jul 19;15(14):3675. doi: 10.3390/cancers15143675.
2
Overdose of pegfilgrastim: case report.
Int J Clin Pharm. 2012 Oct;34(5):690-2. doi: 10.1007/s11096-012-9653-z. Epub 2012 Jul 21.
本文引用的文献
1
Pegfilgrastim in children with severe congenital neutropenia.
Pediatr Blood Cancer. 2010 Mar;54(3):465-7. doi: 10.1002/pbc.22350.
2
Respiratory distress and sudden death of a patient with GSDIb chronic neutropenia: possible role of pegfilgrastim.
Haematologica. 2009 Aug;94(8):1175-7. doi: 10.3324/haematol.2008.005330.
3
Is pegfilgrastim safe and effective in congenital neutropenia? An analysis of the French Severe Chronic Neutropenia registry.
Pediatr Blood Cancer. 2009 Dec;53(6):1068-73. doi: 10.1002/pbc.22147.
4
Pegylated granulocyte colony-stimulating factor mobilizes CD34+ cells with different stem and progenitor subsets and distinct functional properties in comparison with unconjugated granulocyte colony-stimulating factor.
Haematologica. 2008 Mar;93(3):347-55. doi: 10.3324/haematol.12081. Epub 2008 Feb 11.
5
Serum pegfilgrastim concentrations during recovery of absolute neutrophil count in patients with cancer receiving pegfilgrastim after chemotherapy.
Pharmacotherapy. 2007 Oct;27(10):1387-93. doi: 10.1592/phco.27.10.1387.
6
Long term results of a randomized study performed by Intergruppo Italiano Linfomi comparing Mini-CEOP vs P-VEBEC in elderly patients with diffuse large B-cell lymphoma.
Leuk Lymphoma. 2007 Feb;48(2):367-73. doi: 10.1080/10428190601078100.
7
A randomized double-blind multicenter phase III study of fixed-dose single-administration pegfilgrastim versus daily filgrastim in patients receiving myelosuppressive chemotherapy.
Ann Oncol. 2003 Jan;14(1):29-35. doi: 10.1093/annonc/mdg019.
8
Comparable efficacy and safety profiles of once-per-cycle pegfilgrastim and daily injection filgrastim in chemotherapy-induced neutropenia: a multicenter dose-finding study in women with breast cancer.
Ann Oncol. 2002 Jun;13(6):903-9. doi: 10.1093/annonc/mdf130.
9
Functional features of neutrophils induced by G-CSF and GM-CSF treatment: differential effects and clinical implications.
Leukemia. 1997 Apr;11(4):466-78. doi: 10.1038/sj.leu.2400607.
10
Impairment in gas exchange after granulocyte colony stimulating factor (G-CSF) in a patient with the adult respiratory distress syndrome.
Chest. 1995 Jan;107(1):276-8. doi: 10.1378/chest.107.1.276.
Zotero 插件